Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toxicity during induction of pulsed versus continuous prednisolone in children with acute lymphoblastic leukaemia: a multi-centre, open label, randomised, phase 3 trial from India (2016-2022).

The Lancet regional health. Southeast Asia·2026
Same author

Fulminant paraneoplastic Ma2 (PNMA2) and zinc finger protein of the cerebellum 4 (ZIC4) antibody-positive encephalitis in triple-negative breast cancer treated with pembrolizumab.

BMJ case reports·2026
Same author

Management of toxicities from antibody - drug conjugates in breast cancer.

Frontiers in oncology·2026
Same author

Integrated Genomic Profiling of Newly Diagnosed and Relapsed Acute Myeloid Leukemia Identifies Driver Genes, Mutational Signatures, and Therapeutic Targets.

Cancers·2026
Same author

Pertuzumab-Docetaxel-Trastuzumab regimen in HER2-positive metastatic breast cancer: Real-world data from India.

Cancer treatment and research communications·2026
Same author

Lymph Node Ratio as an Independent Prognostic Factor in Breast Cancer: A Retrospective Study of 4060 Patients Undergoing Axillary Lymph Node Dissection.

Clinical breast cancer·2026

Related Experiment Video

Updated: Apr 30, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

13.9K

Mediastinal granulocytic sarcoma: poor risk AML?

Ajay Gogia, Atul Sharma, Anita Chopra

    Journal of the Indian Medical Association
    |May 3, 2014
    PubMed
    Summary

    Granulocytic sarcoma, a rare AML manifestation, can present as mediastinal masses causing SVC syndrome. Despite standard therapy, these AML cases with normal cytogenetics showed poor outcomes.

    Area of Science:

    • Hematology
    • Oncology
    • Pathology

    Background:

    • Granulocytic sarcoma (GS) is an extramedullary tumor of myeloid blasts.
    • It is a rare manifestation of acute myeloid leukemia (AML).
    • GS commonly affects skin, orbits, gingiva, maxilla, and lymph nodes.

    Observation:

    • This report details three AML cases with normal cytogenetics presenting with mediastinal masses.
    • These masses led to superior vena cava (SVC) syndrome.
    • GS in the mediastinum is often misdiagnosed as lymphoma or germ cell tumors.

    Findings:

    • All three AML patients received standard leukemia treatment.
    • Despite treatment, the patients with mediastinal GS experienced poor outcomes.
    • Normal cytogenetics did not predict a favorable response in these cases.

    More Related Videos

    Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice
    10:02

    Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice

    Published on: January 6, 2023

    2.1K
    Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
    06:33

    Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

    Published on: November 10, 2023

    2.0K

    Related Experiment Videos

    Last Updated: Apr 30, 2026

    Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
    09:01

    Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

    Published on: March 26, 2018

    13.9K
    Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice
    10:02

    Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice

    Published on: January 6, 2023

    2.1K
    Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
    06:33

    Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

    Published on: November 10, 2023

    2.0K

    Implications:

    • Mediastinal GS in AML requires careful diagnostic consideration to avoid misclassification.
    • The presentation of mediastinal masses in AML, even with normal cytogenetics, may indicate a poor prognosis.
    • Further research is needed to understand the biology and optimize treatment for mediastinal GS in AML.